How it works
Tirzepatide is a once-weekly injectable dual glucagon-like peptide 1 (GLP-1) receptor and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. It works by increasing insulin production and lowering glucagon secretion as well as targeting areas in the brain that regulate appetite and food intake. A small change in the molecule allows the drug to last weeks in our bodies rather than the natural version our bodies make, which lasts minutes.
Cyanocobalamin (Vitamin B12) is added to support nutrient repletion and may help mitigate nausea-related side effects. Glycine is added to help inhibit the deterioration of protein tissue that forms muscles. Studies show that administering glycine during calorie restriction may be beneficial for preserving muscle mass and loss of fat tissue.
If prescribed, your clinician starts you on a low dose and titrates upward over several weeks so your body adjusts gradually rather than all at once.




